Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions that are not adequately addressed by current treatments. For more information, please visit www.hemostemix.com.
View Top Employees from Hemostemix Inc.Website | http://www.hemostemix.com |
Ticker | HEM |
Revenue | $28 million |
Employees | 13 (11 on RocketReach) |
Founded | 2006 |
Address | 300 5th Ave SW Ste 2150, Calgary, Alberta T2P 3C4, CA |
Phone | (403) 506-3373 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Cell Therapy, Business Services, Science and Engineering, Other Pharmaceuticals and Biotechnology, Critical Limb Ischemia, Clinical Trials, Peripheral Artery Disease, Health Care, Cardiovascular Disease, Therapeutics |
Web Rank | 17 Million |
Keywords | Hemostemix, Hemostemix Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Hemostemix Inc. employee's phone or email?
The Hemostemix Inc. annual revenue was $28 million in 2023.
Peter Pavlin is the Vice President Operations of Hemostemix Inc..
11 people are employed at Hemostemix Inc..
Hemostemix Inc. is based in Calgary, Alberta.
The NAICS codes for Hemostemix Inc. are [541, 54, 5417, 54171, 541714].
The SIC codes for Hemostemix Inc. are [87, 873].